Modular mechanisms of immune priming and growth inhibition mediated by plant effector-triggered immunity
Himanshu ChhillariD, Hoang Hung Nguyen, Pei-Min Yeh, Jonathan D.G. Jones, Pingtao DingiD
Abstract
Excessive activation of effector-triggered immunity (ETI) in plants inhibits plant growth and activates cell death. ETI mediated by intracellular Toll/Interleukin-1 receptor/Resistance protein (TIR) nucleotide-binding leucine-rich-repeat receptors (NLRs) involves two partially redundant signalling nodes in Arabidopsis, EDS1-PAD4-ADR1 and EDS1-SAG101-NRG1. Genetic and transcriptomic analyses show that EDS1-PAD4-ADR1 primarily enhances the immune component abundance and is critical for limiting pathogen growth, whereas EDS1-SAG101-NRG1 mainly activates the hypersensitive cell death response (HR) but is dispensable for immune priming. This study enhances our understanding of the distinct contributions of these two signalling modules to ETI and suggests potential strategies for improving disease resistance in crops without compromising yield.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Activation of TIR signaling is required for pattern-triggered immunity
- Pattern-recognition receptors are required for NLR-mediated plant immunity
- TIR signaling promotes the interactions between EDS1/PAD4 and ADR1-L1 and oligomerization of ADR1-L1
- A Cross-kingdom Effector Modulates EDS1-dependent TIR-NLR-mediated Plant Immunity
Md Musharaf Hossain, Yangdou Wei, … Christopher D. Todd·bioRxiv·May 22, 2026
- Arabidopsis cell surface LRR immune receptor signaling through the EDS1-PAD4-ADR1 node
R. N. Pruitt, L. Zhang, … T. Nürnberger·bioRxiv·Nov 23, 2020
- Plant TIR domains physically interact with EDS1 family proteins to propagate immune signalling.
J. Chen, X. Zhang, … P. N. Dodds·bioRxiv·Aug 2, 2023